The Partnership for Safe Medicines has been publishing information about the counterfeit drug problem around the world for more than a decade. With experts leading the organization and a committed and passionate set of writers and editors, our content is more in-depth than many other sources, which simply copy links to the news from other websites.
Watch our new ad: “Congress: Don’t invite global drug counterfeiters to the U.S. Drug Supply” As the pandemic upended our daily lives, illegally-imported counterfeit products flooded into our communities. Criminals all over the world moved quickly to exploit fear and take advantage of disrupted supply lines in March 2020. Americans were-and continue to be-deluged in…
PSM holds its 2022 congressional briefing. A study of FDA enforcement actions underscores the real threat of fake drugs; a New York pharmacy-owner who allegedly sold fake HIV drugs is sentenced in a different crime; large amphetamine pill seizures in Montreal and Jordan; and stories relating to pressed counterfeit pills in 16 states.
Trafficking pharmaceuticals or illicit drugs violates Facebook’s community guidelines, but drug dealers are advertising them on Facebook anyway–even after they’ve been reported. Watch to learn more.
In this week’s news: counterfeit pills made with isotonitazene in the DC-area; Drug resistant malaria and a prescription drug bust in Africa; a former health minister goes to prison over fake medicines in Vietnam; and news about pressed pills in 15 states.
The CDC releases preliminary data suggesting that drug deaths climbed 15% in 2021; the DEA reports on fentanyl precursor seizures and 28 more stories cover deaths, seizures and prosecutions across the country.
This is a reprint of an FDA Alert. Mesa Biotech, Inc., Recalls Certain Accula SARS-CoV-2 Tests for Risk of False Positives Caused by Contamination The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product Product Name: Accula…
This is a reprint of an FDA Alert. Do Not Use Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test: FDA Safety Communication May 10, 2022 The U.S. Food and Drug Administration (FDA) is warning people not to use the Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold). This test is not authorized, cleared, or approved…
This counterfeit HIV drug outbreak inspired Brandon Mascata of ADAP Advocacy Association (AAA+) to team up with us to produce an educational advertisement for people living with HIV and their loved ones.
This week: fake Flowflex COVID-19 and iHealth COVID-19 antigen test kits, large prescription drugs seizures, a new bill in the Senate and 27 more stories involving pressed pills.
What have we learned about counterfeit medicines during the pandemic? And what does it mean for proposals to import the drug supplies of other countries like Canada?